Attached files

file filename
EX-99.1 - PRESS RELEASE - ROTECH HEALTHCARE INCa20120809exhibit991.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________ 
FORM 8-K
______________________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 9, 2012


______________________________________ 
ROTECH HEALTHCARE INC.
(Exact name of registrant as specified in its charter)
______________________________________ 

 
 
 
 
 
 
 
 
Delaware
0-50940
03-0408870
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(IRS Employer
Identification No.)
 
 
 
 
 
 
 
 
2600 Technology Drive, Suite 300, Orlando, Florida
 
32804
(Address of principal executive offices)
 
(Zip Code)

Registrant's telephone number, including area code (407) 822-4600

Not Applicable
(Former name or former address, if changed since last report.)
______________________________________ 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 14e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







Item 2.02. Results of Operations and Financial Condition.

On August 9, 2012, Rotech Healthcare Inc. (the "Company") announced its financial results for the second quarter ended June 30, 2012. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. All of the information furnished in this report and the accompanying exhibit shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.


Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Press Release

Exhibit No.    Description
 
 
 
Exhibit No.
Description
99.1
Press Release of the Company dated August 9, 2012.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ROTECH HEALTHCARE INC.

 
 
 
 
 
 
Dated August 9, 2012
By     /s/ Philip L. Carter     
Name    Philip L. Carter
Title    President & Chief Executive Officer